APOA1 and obesity due to melanocortin 4 receptor deficiency: The findings underscore the profound impact of obesity and glycemic status on insulin resistance and lipid abnormalities while also suggesting that APOA1 genotype may not independently influence these metabolic outcomes within obese subgroups.